Annual CFI
-$44.46 M
+$69.72 M+61.06%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual cash flow from investing activities is -$44.46 million, with the most recent change of +$69.72 million (+61.06%) on December 31, 2023.
- During the last 3 years, ZNTL annual CFI has risen by +$240.37 million (+84.39%).
- ZNTL annual CFI is now -19485.02% below its all-time high of -$227.00 thousand, reached on December 31, 2018.
Performance
ZNTL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$48.24 M
+$13.75 M+39.88%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly cash flow from investing activities is $48.24 million, with the most recent change of +$13.75 million (+39.88%) on September 30, 2024.
- Over the past year, ZNTL quarterly CFI has increased by +$165.69 million (+141.08%).
- ZNTL quarterly CFI is now -33.85% below its all-time high of $72.93 million, reached on June 30, 2023.
Performance
ZNTL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$102.22 M
+$165.69 M+261.03%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL TTM cash flow from investing activities is $102.22 million, with the most recent change of +$165.69 million (+261.03%) on September 30, 2024.
- Over the past year, ZNTL TTM CFI has increased by +$116.51 million (+815.21%).
- ZNTL TTM CFI is now -17.02% below its all-time high of $123.18 million, reached on June 30, 2023.
Performance
ZNTL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ZNTL Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +61.1% | +141.1% | +815.2% |
3 y3 years | +84.4% | +141.1% | +815.2% |
5 y5 years | -10000.0% | +141.1% | +815.2% |
ZNTL Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -145.4% | +61.1% | -33.9% | +133.9% | -17.0% | +146.4% |
5 y | 5-year | <-9999.0% | +84.4% | -33.9% | +133.9% | -17.0% | +135.9% |
alltime | all time | <-9999.0% | +84.4% | -33.9% | +133.9% | -17.0% | +135.9% |
Zentalis Pharmaceuticals Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $48.24 M(+39.9%) | $102.22 M(-261.0%) |
Jun 2024 | - | $34.49 M(-44.0%) | -$63.48 M(+153.6%) |
Mar 2024 | - | $61.55 M(-246.3%) | -$25.03 M(-43.7%) |
Dec 2023 | -$44.46 M(-61.1%) | -$42.06 M(-64.2%) | -$44.46 M(+211.1%) |
Sep 2023 | - | -$117.45 M(-261.0%) | -$14.29 M(-111.6%) |
Jun 2023 | - | $72.93 M(+73.1%) | $123.18 M(-234.1%) |
Mar 2023 | - | $42.12 M(-454.1%) | -$91.86 M(-19.6%) |
Dec 2022 | -$114.18 M(+530.3%) | -$11.89 M(-159.4%) | -$114.18 M(+93.5%) |
Sep 2022 | - | $20.02 M(-114.1%) | -$59.02 M(-73.2%) |
Jun 2022 | - | -$142.10 M(-817.8%) | -$220.48 M(+1772.1%) |
Mar 2022 | - | $19.80 M(-54.2%) | -$11.78 M(-35.0%) |
Dec 2021 | -$18.11 M | $43.27 M(-130.6%) | -$18.11 M(-74.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$141.44 M(-312.4%) | -$71.03 M(+5.3%) |
Jun 2021 | - | $66.60 M(+394.9%) | -$67.48 M(-75.1%) |
Mar 2021 | - | $13.46 M(-239.5%) | -$271.34 M(-4.7%) |
Dec 2020 | -$284.83 M(>+9900.0%) | -$9.65 M(-93.0%) | -$284.83 M(+3.5%) |
Sep 2020 | - | -$137.89 M(+0.5%) | -$275.22 M(+100.3%) |
Jun 2020 | - | -$137.26 M(>+9900.0%) | -$137.44 M(>+9900.0%) |
Mar 2020 | - | -$31.00 K(-13.9%) | -$342.00 K(-2.8%) |
Dec 2019 | -$352.00 K(+55.1%) | -$36.00 K(-66.4%) | -$352.00 K(+11.4%) |
Sep 2019 | - | -$107.00 K(-36.3%) | -$316.00 K(+51.2%) |
Jun 2019 | - | -$168.00 K(+309.8%) | -$209.00 K(+409.8%) |
Mar 2019 | - | -$41.00 K | -$41.00 K |
Dec 2018 | -$227.00 K | - | - |
FAQ
- What is Zentalis Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual CFI year-on-year change?
- What is Zentalis Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly CFI year-on-year change?
- What is Zentalis Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals TTM CFI year-on-year change?
What is Zentalis Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ZNTL is -$44.46 M
What is the all time high annual CFI for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual cash flow from investing activities is -$227.00 K
What is Zentalis Pharmaceuticals annual CFI year-on-year change?
Over the past year, ZNTL annual cash flow from investing activities has changed by +$69.72 M (+61.06%)
What is Zentalis Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ZNTL is $48.24 M
What is the all time high quarterly CFI for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly cash flow from investing activities is $72.93 M
What is Zentalis Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ZNTL quarterly cash flow from investing activities has changed by +$165.69 M (+141.08%)
What is Zentalis Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ZNTL is $102.22 M
What is the all time high TTM CFI for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high TTM cash flow from investing activities is $123.18 M
What is Zentalis Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ZNTL TTM cash flow from investing activities has changed by +$116.51 M (+815.21%)